Content deleted Content added
Ozzie10aaaa (talk | contribs) →History: join |
m Clean up spacing errors around ref tags., replaced: /ref>T → /ref> T |
||
Line 1:
{{Short description|Program sponsored by the U.S. National Institutes of Health}}
The '''Terry Beirn Community Programs for Clinical Research on AIDS''' ('''CPCRA''') was a program sponsored by [[National Institutes of Health]] (NIH) in the United States.<ref>{{Cite journal | doi=10.1007/BF01964462|title = Clinical programs for clinical research on AIDS: Description of a randomized prospective study of clindamycin versus pyrimethamine for prevention of ''Toxoplasma'' gondii infection| journal=European Journal of Clinical Microbiology & Infectious Diseases| volume=10| issue=3| pages=195–198|year = 1991|last1 = Jacobson|first1 = M. A.| last2=Besch| first2=C. L.| last3=Child| first3=C.| last4=Hafner| first4=R.| last5=Muth| first5=K.| last6=Deyton| first6=L.|pmid = 1676364|s2cid = 8673486}}</ref><ref>{{cite journal |url=http://cpcra.s-3.com/docs/pubs/papers/Method-Cox.pdf |journal=Health Soc Work |date=November 1998 |volume=23 |issue=4 |pages=290–7 |title=Community advisory boards: their role in AIDS clinical trials. Terry Beirn Community Programs for Clinical Research on AIDS |last1=Cox |first1=LE |last2=Rouff |first2=JR |last3=Svendsen |first3=KH |last4=Markowitz |first4=M |last5=Abrams |first5=DI |doi=10.1093/hsw/23.4.290 |pmid=9834882 |access-date=2016-04-21 |archive-url=https://web.archive.org/web/20160427095424/http://cpcra.s-3.com/docs/pubs/papers/Method-Cox.pdf |archive-date=2016-04-27 |url-status=dead }}</ref> Started in 1989, CPCRA was instrumental in some research databases being established. Research from the programs assisted the evaluation of therapies for treating [[HIV]] in diverse populations.{{
==History==
Line 13:
==Research==
An [[antiretroviral]] medication self-reporting questionnaire was developed by the program.<ref>{{cite journal |title=The Consistency of Adherence to Antiretroviral Therapy Predicts Biologic Outcomes for Human Immunodeficiency Virus—Infected Persons in Clinical Trials |first1=Sharon |last1=Mannheimer |first2=Gerald |last2=Friedland |first3=John |last3=Matts |first4=Carroll |last4=Child |first5=Margaret |last5=Chesney |journal=Clinical Infectious Diseases |year=2002 |volume=34 |issue=8 |pages=1115–21 |doi=10.1086/339074 |pmid=11915001|doi-access=free }}</ref> The program organised the 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial: a large, long-term, randomised, prospective comparison of three different [[antiretroviral]] strategies in [[highly active antiretroviral therapy]]-naïve, HIV-1-infected persons.<ref>{{cite journal |title=The rationale and design of the CPCRA (Terry Beirn Community Programs for Clinical Research on AIDS) 058 FIRST (Flexible Initial Retrovirus Suppressive Therapies) trial |last1=MacArthur |first1=RD |last2=Chen |first2=L |last3=Mayers |first3=DL |last4=Besch |first4=CL |last5=Novak |first5=R |last6=van den Berg-Wolf |first6=M |last7=Yurik |first7=T |last8=Peng |first8=G |last9=Schmetter |first9=B |last10=Brizz |first10=B |last11=Abrams |first11=D |journal=Control Clin Trials |date=April 2001 |volume=22 |issue=2 |pages=176–90 |doi=10.1016/S0197-2456(01)00111-8|pmid=11306155 }}</ref>
==References==
| |||